Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gray Cary Ware & Freidenrich was a premier American law firm that specialized in representing high-growth technology and life sciences companies. Headquartered in San Diego and Silicon Valley, the firm was a central figure in the development of the biotechnology industry, providing essential legal services for venture capital financing, intellectual property litigation, and initial public offerings. In 2005, Gray Cary merged with Piper Rudnick and the UK-based firm DLA to form DLA Piper, which became one of the largest law firms in the world. The firm's legacy is defined by its role in the San Diego biotech cluster, where it represented major industry pioneers such as IDEC Pharmaceuticals. Its expertise spanned corporate law, securities, and patent protection for emerging growth companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gray Cary.